166

Pulmonology
Focuses on lung health.
Sub Categories on Pulmonology
Latest Articles
Common bacterial infection may trigger lung transplant rejection

Common bacterial infection may trigger lung transplant rejection

by Bob Yirka , Medical XpressPseudomonas-induced antibody-mediated rejection of lung allografts in mice. Credit:Science Translational Medicine(2025). DOI: 10.1126/scitranslmed.adu6563A lar

Common bacterial infection may trigger lung transplant rejection

by Bob Yirka , Medical XpressPseudomonas-induced antibody-mediated rejection of lung allografts in mice. Credit:Science Translational Medicine(2025). DOI: 10.1126/scitranslmed.adu6563A lar
High-flow nasal oxygen noninferior to noninvasive ventilation for acute respiratory failure

High-flow nasal oxygen noninferior to noninvasive ventilation for acute respiratory failure

High-flow nasal oxygen noninferior to noninvasive ventilation for acute respiratory failureby Lori SolomonHigh-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal

High-flow nasal oxygen noninferior to noninvasive ventilation for acute respiratory failure

High-flow nasal oxygen noninferior to noninvasive ventilation for acute respiratory failureby Lori SolomonHigh-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal
Common cough syrup ingredient offers hope for lung fibrosis patients

Common cough syrup ingredient offers hope for lung fibrosis patients

by Andreia Pinho,European Molecular Biology LaboratoryA new study has explored the potential of Dextromethorphan, an FDA-approved drug, in the treatment of lung fibrosis. Lung fibrosis occurs af

Common cough syrup ingredient offers hope for lung fibrosis patients

by Andreia Pinho,European Molecular Biology LaboratoryA new study has explored the potential of Dextromethorphan, an FDA-approved drug, in the treatment of lung fibrosis. Lung fibrosis occurs af
Study examines development of early COPD in ages 30 to 55

Study examines development of early COPD in ages 30 to 55

by COPD FoundationDistribution of Forced Expiratory Volume in 1 Second Trajectory from COPD Cohort Studies, Based on Presence or Absence of GOLD Grade ≥2 at the Final Exam. Credit:Chronic Obstru

Study examines development of early COPD in ages 30 to 55

by COPD FoundationDistribution of Forced Expiratory Volume in 1 Second Trajectory from COPD Cohort Studies, Based on Presence or Absence of GOLD Grade ≥2 at the Final Exam. Credit:Chronic Obstru
Patient perspectives central for developing new therapies for COPD

Patient perspectives central for developing new therapies for COPD

by COPD FoundationThe mechanistic model is a logical link between patient-inspired health concepts, a drug's mechanism of action, and subset of measures selected to test and communicate product-sp

Patient perspectives central for developing new therapies for COPD

by COPD FoundationThe mechanistic model is a logical link between patient-inspired health concepts, a drug's mechanism of action, and subset of measures selected to test and communicate product-sp
When Lung Cancer Spreads to the Liver

When Lung Cancer Spreads to the Liver

When Lung Cancer Spreads to the LiverSymptoms, Treatments, and PrognosisByLynne Eldridge, MDUpdated on August 11, 2022Medically reviewed byGagandeep Brar, MDLung cancer spread

When Lung Cancer Spreads to the Liver

When Lung Cancer Spreads to the LiverSymptoms, Treatments, and PrognosisByLynne Eldridge, MDUpdated on August 11, 2022Medically reviewed byGagandeep Brar, MDLung cancer spread
Research: Insufficient evidence to recommend low-dose CT screening in never smokers

Research: Insufficient evidence to recommend low-dose CT screening in never smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early

Research: Insufficient evidence to recommend low-dose CT screening in never smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early
Taletrectinib shows clinically meaningful response and favorable safety in ROS1+ non-small cell lung cancer

Taletrectinib shows clinically meaningful response and favorable safety in ROS1+ non-small cell lung cancer

Taletrectinib shows clinically meaningful response and favorable safety in ROS1+ non-small cell lung cancerby International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe

Taletrectinib shows clinically meaningful response and favorable safety in ROS1+ non-small cell lung cancer

Taletrectinib shows clinically meaningful response and favorable safety in ROS1+ non-small cell lung cancerby International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe